Digistain logo (teal)
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
✕
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
Contact us

admin

  • Home
  • News
  • admin
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Awards
  • Conferences
  • Digistain
  • Funding
  • Healthcare
  • News
  • All
  • All
  • admin
January 28, 2023
2023 FINALIST LOGOS Advances Digital Healthcar
January 28, 2023
Categories
  • Awards

Medilink Business Awards 2023

Delighted to be shortlisted as a finalist at the Medilink Business Awards 2023 for not one but two categories! Advances in Digital Health and for Achievement […]
Do you like it?
Read more
January 28, 2023
The Indian Express logo.svg
January 28, 2023
Categories
  • News

indianexpress.com

Excited to be featured in the Indian national news this weekend.
Do you like it?
Read more
December 10, 2022
WhatsApp Image 2022 12 09 at 20.12.25
December 10, 2022
Categories
  • Conferences

#sabcs2022 

Thankful for the opportunity to unveil our latest clinical study at San Antonio Breast Cancer Symposium this week! #sabcs2022 #oncology #breastcancer
Do you like it?
Read more
November 6, 2022
BBC Radio logo.svg
November 6, 2022
Categories
  • News

Dr Hemmel Amrania on BBC Three Counties Radio

Pleased to be on the radio again talking about our mission here at Digistain to improve access to recurrence-risk testing.  
Do you like it?
Read more
November 2, 2022
BBC Radio logo.svg
November 2, 2022
Categories
  • News

DigiStain’s CEO Dr Hemmel Amrania on BBC Radio

On the BBC today talking about British patient access to emerging technologies and the challenges health-tech companies face in the widespread adoption of their technologies in […]
Do you like it?
Read more
October 26, 2022
WhatsApp Image 2022 10 30 at 07.11.16
October 26, 2022
Categories
  • Conferences

The MedTech Conference

Excited to be in Boston, MA for the Med Tech Conference. Here Digistain is keeping up to date on the latest health-tech updates and regulatory changes
Do you like it?
Read more
October 24, 2022
iop logo 1
October 24, 2022
Categories
  • Awards

Digistain wins the Institute of Physics Innovation award

Digistain wins the Institute of Physics Innovation Business Start-Up Award 2022 @PhysicsNews for a biomedical implementation of infrared vibrational spectroscopy.
Do you like it?
Read more
October 22, 2022
WhatsApp Image 2022 10 24 at 05.14.42 4
October 22, 2022
Categories
  • Conferences

Pat Whitworth presents Digistain

Pat Whitworth ex-Chairman of the American Society of Breast Surgeons and Committee member of TME presented Digistain.
Do you like it?
Read more
October 12, 2022
hemmel skynews
October 12, 2022
Categories
  • News

DigiStain’s CEO Dr Hemmel Amrania LIVE on Sky NEWS UK

Digistain is UKCA-marked and registered with the MHRA. Dr Hemmel Amrania on Sky News.  
Do you like it?
Read more
Prev page
123456
Next page
Digistain

Digistain is a cancer biomarker company. Its breast cancer recurrence-risk test measures the tumour’s biochemistry directly, with results before the next appointment.

LRQA certified ISO 13485

Platform

  • Overview
  • How it works
  • Research and pipeline
  • Publications

Digistain Breast

  • Overview
  • For clinicians
  • For laboratories
  • For patients

Company

  • Partners
  • Investors
  • About
  • Team
  • News
  • Contact
© 2026 Digistain Ltd · ISO 13485:2016 certified (LRQA) for the design and development of IVD software used in cancer management · Privacy policy · Terms and conditions · Cookie policy